SG148195A1 - Plasmids coding for p185neu protein sequence variants and therapeutic uses thereof - Google Patents
Plasmids coding for p185neu protein sequence variants and therapeutic uses thereofInfo
- Publication number
- SG148195A1 SG148195A1 SG200808639-9A SG2008086399A SG148195A1 SG 148195 A1 SG148195 A1 SG 148195A1 SG 2008086399 A SG2008086399 A SG 2008086399A SG 148195 A1 SG148195 A1 SG 148195A1
- Authority
- SG
- Singapore
- Prior art keywords
- protein sequence
- sequence variants
- therapeutic uses
- plasmids coding
- coding
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/64—General methods for preparing the vector, for introducing it into the cell or for selecting the vector-containing host
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/001102—Receptors, cell surface antigens or cell surface determinants
- A61K39/001103—Receptors for growth factors
- A61K39/001106—Her-2/neu/ErbB2, Her-3/ErbB3 or Her 4/ErbB4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Mycology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT001965A ITMI20041965A1 (it) | 2004-10-15 | 2004-10-15 | "dna codificante forme tronche e chimeriche della proteina p185neu e suoi usi terapeutici" |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG148195A1 true SG148195A1 (en) | 2008-12-31 |
Family
ID=35539028
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG200808639-9A SG148195A1 (en) | 2004-10-15 | 2005-10-13 | Plasmids coding for p185neu protein sequence variants and therapeutic uses thereof |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US7985582B2 (da) |
| EP (2) | EP1809668A2 (da) |
| JP (1) | JP5597346B2 (da) |
| KR (1) | KR101337706B1 (da) |
| CN (2) | CN101886090B (da) |
| AT (1) | ATE524494T1 (da) |
| AU (1) | AU2005293218B2 (da) |
| CA (1) | CA2583499C (da) |
| DK (1) | DK1939217T3 (da) |
| ES (1) | ES2370540T3 (da) |
| HK (1) | HK1150627A1 (da) |
| HR (1) | HRP20110729T1 (da) |
| IL (1) | IL182510A0 (da) |
| IT (1) | ITMI20041965A1 (da) |
| NO (1) | NO344353B1 (da) |
| PL (1) | PL1939217T3 (da) |
| PT (1) | PT1939217E (da) |
| RU (1) | RU2383620C2 (da) |
| SG (1) | SG148195A1 (da) |
| SI (1) | SI1939217T1 (da) |
| WO (1) | WO2006040660A2 (da) |
| ZA (1) | ZA200703875B (da) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101638440B (zh) * | 2008-07-29 | 2011-10-26 | 中国人民解放军军事医学科学院基础医学研究所 | 一种可诱发机体抗肿瘤免疫的异种抗原-Fc融合蛋白及其应用 |
| EP2777711A1 (en) | 2013-03-11 | 2014-09-17 | Icon Genetics GmbH | Her2/Neu cancer vaccine |
| US11667960B2 (en) * | 2016-04-20 | 2023-06-06 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Methods and systems for RNA or DNA detection and sequencing |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5518885A (en) * | 1994-04-19 | 1996-05-21 | The United States Of America As Represented By The Department Of Health & Human Services | ERBB2 promoter binding protein in neoplastic disease |
| US7794729B2 (en) | 1994-11-08 | 2010-09-14 | The Trustees Of The University Of Pennsylvania | Methods and compositions for immunotherapy of cancer |
| US7820180B2 (en) * | 2004-09-24 | 2010-10-26 | The Trustees Of The University Of Pennsylvania | Listeria-based and LLO-based vaccines |
| BR0007840A (pt) | 1999-01-29 | 2002-01-22 | Corixa Corp | Proteìnas de fusão her-2/neu |
| US20020177551A1 (en) | 2000-05-31 | 2002-11-28 | Terman David S. | Compositions and methods for treatment of neoplastic disease |
| AU2003286770A1 (en) * | 2002-10-30 | 2004-06-07 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | METHODS FOR PROPHYLAXIS AND TREATMENT OF HER-2/neu TUMORS |
| DE10251520A1 (de) * | 2002-11-04 | 2004-05-13 | Valeo Wischersysteme Gmbh | Adapter für ein Wischblatt |
| US20040253606A1 (en) * | 2002-11-26 | 2004-12-16 | Protein Design Labs, Inc. | Methods of detecting soft tissue sarcoma, compositions and methods of screening for soft tissue sarcoma modulators |
| ITMI20031942A1 (it) | 2003-10-09 | 2005-04-10 | Indena Spa | Dna codificante p185^neu e suoi usi terapeutici |
-
2004
- 2004-10-15 IT IT001965A patent/ITMI20041965A1/it unknown
-
2005
- 2005-10-13 US US11/665,301 patent/US7985582B2/en active Active
- 2005-10-13 PL PL08004513T patent/PL1939217T3/pl unknown
- 2005-10-13 AT AT08004513T patent/ATE524494T1/de active
- 2005-10-13 EP EP05795953A patent/EP1809668A2/en not_active Withdrawn
- 2005-10-13 KR KR1020077010630A patent/KR101337706B1/ko active IP Right Grant
- 2005-10-13 SI SI200531425T patent/SI1939217T1/sl unknown
- 2005-10-13 ES ES08004513T patent/ES2370540T3/es active Active
- 2005-10-13 AU AU2005293218A patent/AU2005293218B2/en active Active
- 2005-10-13 CN CN2010101923839A patent/CN101886090B/zh active Active
- 2005-10-13 CN CNA2005800400573A patent/CN101065399A/zh active Pending
- 2005-10-13 CA CA2583499A patent/CA2583499C/en active Active
- 2005-10-13 RU RU2007117894/13A patent/RU2383620C2/ru active
- 2005-10-13 JP JP2007536284A patent/JP5597346B2/ja active Active
- 2005-10-13 SG SG200808639-9A patent/SG148195A1/en unknown
- 2005-10-13 DK DK08004513.1T patent/DK1939217T3/da active
- 2005-10-13 ZA ZA200703875A patent/ZA200703875B/xx unknown
- 2005-10-13 EP EP08004513A patent/EP1939217B1/en active Active
- 2005-10-13 PT PT08004513T patent/PT1939217E/pt unknown
- 2005-10-13 WO PCT/IB2005/003052 patent/WO2006040660A2/en active Application Filing
-
2007
- 2007-04-12 IL IL182510A patent/IL182510A0/en active IP Right Grant
- 2007-05-14 NO NO20072457A patent/NO344353B1/no unknown
-
2011
- 2011-05-09 HK HK11104573.4A patent/HK1150627A1/xx unknown
- 2011-06-30 US US13/173,339 patent/US8207141B2/en active Active
- 2011-10-11 HR HR20110729T patent/HRP20110729T1/hr unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60028970D1 (de) | An her2 bindende peptidverbindungen | |
| WO2005116051A3 (de) | An mhc-moleküle bindende tumor-assoziierte peptide | |
| TW200508214A (en) | Novel compounds | |
| IL171914A0 (en) | Variants of il-18bp, their preparation and pharmaceutical compositions containing them | |
| HK1101131A1 (en) | Proteins belonging to the bcl-2 family and fragments thereof, and their use in cancer patients | |
| IL173348A (en) | Thienopyridine compounds, pharmaceuticals containing them and their use in the preparation of drugs | |
| MX2010005783A (es) | Secuencias de aminoacidos dirigidas contra citoquinas heterodimericas y/o sus receptores y polipeptidos que comprenden las mismas. | |
| IL176007A0 (en) | Antibodies specific to c35 and pharmaceutical compositions containing the same | |
| NO20055209L (no) | Peptabody for cancerbehandling | |
| WO2004016643A3 (en) | Tumor associated antigen, peptides thereof, and use of same as anti-tumor vaccines | |
| HK1121670A1 (en) | Preparation and composition of inter-alpha inhibitor proteins from human plasma for therapeutic use | |
| SG148195A1 (en) | Plasmids coding for p185neu protein sequence variants and therapeutic uses thereof | |
| IL207012A (en) | 28sgp medicinal product and 28sgp accent cancer treatment vaccine | |
| RS20050577A (en) | Compositions and methods for treating cancer using igsf9 and liv-1 | |
| NO20061542L (no) | P185neu-Kodende DNA samt terapeutiske anvendelser derav | |
| WO2005037236A3 (en) | Novel heat shock protein 20-related polypeptides and uses therefor | |
| WO2003093298A3 (en) | Immunogenic peptides | |
| WO2004085461A3 (de) | An mhc-moleküle bindende tumor-assoziierte peptide | |
| WO2001057069A3 (en) | Targeting peptides | |
| WO2003022874A1 (en) | Antagonist peptides to vegr receptor flt-1 | |
| WO2005075646A8 (ja) | ストレス誘導抗アポトーシス分子（ｉｅｘ−１）由来ペプチド | |
| AU2003296543A8 (en) | Peptides having a high cysteine content | |
| EA200600987A1 (ru) | Применение сирамезина в лечении злокачественных опухолей |